The ADDovenom project is part of and is administered by the Bristol BioDesign Institute. Work on ADDovenom will be undertaken in the School of Biochemistry which is particularly strong in Synthetic Biology with the BrisSynBio Centre, Structural Biology, Imaging, Single-Molecule Techniques and Cell Biology. The School offers access to top facilities, including the Faculty’s Wolfson Bioimaging and Proteomics Facilities, and the BrisSynBio Biosuite located in the school, as well as crossdisciplinary training of early career researchers. The School has been awarded with the Athena SWAN Silver Award (2018) for excellence in gender equality in STEMM (Science, Technology, Engineering, Mathematics and Medicine). The work described here will take place in the new Max Planck Centre for Minimal Biology in Bristol, which is directed by Berger, Mann and Wolfson and is world class in Synthetic Biology. The University of Bristol will express, purify and characterise ADDobodies and ADDomers, generate a naïve ADDobody library, carry out in vitro selection/evolution by Ribosome Display, provide sample for in cellulo and in vivo characterisation, constructs for manufacturing antivenoms and determine structures.